Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00314
Full Text
Open PDFAbstract
Available in full text
Date
March 13, 2020
Authors
Publisher
Frontiers Media SA